Mesoporous silicon nanoparticles for targeted two-photon theranostics of prostate cancer

Arnaud Chaix; Khaled El Cheikh; Elise Bouffard; Marie Maynadier; Dina Aggad; Vanja Stojanovic; Nikola Knezevic; Marcel Garcia; Philippe Maillard; Alain Morère; Magali Gary-Bobo; Laurence Raehm; Sébastien Richeter; Jean-Olivier Durand; Frédérique Cunin

doi:10.1039/c6tb00690f

Mesoporous silicon nanoparticles for targeted two-photon theranostics of prostate cancer

J Mater Chem B. 2016 Jun 7;4(21):3639-3642. doi: 10.1039/c6tb00690f. Epub 2016 May 13.

Authors

Arnaud Chaix¹, Khaled El Cheikh, Elise Bouffard, Marie Maynadier, Dina Aggad, Vanja Stojanovic, Nikola Knezevic, Marcel Garcia, Philippe Maillard, Alain Morère, Magali Gary-Bobo, Laurence Raehm, Sébastien Richeter, Jean-Olivier Durand, Frédérique Cunin

Affiliation

¹ Institut Charles Gerhardt Montpellier, UMR 5253 CNRS-ENSCM-UM, Ecole Nationale Supérieure de Chimie Montpellier, 8 rue de l'Ecole Normale, 34296 Montpellier, France. frédérique.cunin@enscm.fr durand@univ-montp2.fr.

PMID: 32263302
DOI: 10.1039/c6tb00690f

Abstract

A novel non-toxic porous silicon nanoparticle grafted with a mannose-6-phosphate analogue and applicable in 2-photon imaging and photodynamic therapy was specifically designed for targeting prostate cancer cells.